Patients with B7-H3 high and PD-L1 low expression showed the lowest anti-tumor immune infiltration, the highest collagen level, and the lowest therapeutic responses to multiple therapies, which mostly belong to “armored-cold” tumors. This evidence concerns the gene CD274 and neoplasm.